Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
19.66
-0.08 (-0.41%)
At close: Jan 30, 2025, 4:00 PM
19.41
-0.25 (-1.27%)
After-hours: Jan 30, 2025, 4:23 PM EST
Pulse Biosciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | 0.7 | 1.42 | - | - | |
| Revenue Growth (YoY) | - | - | -50.63% | - | - | - | |
| Cost of Revenue | - | - | 11.94 | 1.97 | - | - | |
| Gross Profit | - | - | -11.24 | -0.55 | - | - | |
| Selling, General & Admin | 19.06 | 15.78 | 25.97 | 33.82 | 23.52 | 22.99 | |
| Research & Development | 29.47 | 27.8 | 20.84 | 28.64 | 26.44 | 24.96 | |
| Operating Expenses | 48.53 | 43.57 | 46.81 | 62.46 | 49.97 | 47.95 | |
| Operating Income | -48.53 | -43.57 | -58.06 | -63.01 | -49.97 | -47.95 | |
| Interest Expense | -1.1 | -1.1 | -0.9 | -0.7 | - | - | |
| Interest & Investment Income | 3.51 | 2.48 | 0.64 | 0.05 | 0.23 | 0.98 | |
| EBT Excluding Unusual Items | -46.12 | -42.2 | -58.32 | -63.66 | -49.73 | -46.97 | |
| Gain (Loss) on Sale of Assets | -0.01 | -0.01 | -0.19 | - | -0.12 | - | |
| Pretax Income | -46.13 | -42.21 | -58.51 | -63.66 | -49.85 | -46.97 | |
| Net Income | -46.13 | -42.21 | -58.51 | -63.66 | -49.85 | -46.97 | |
| Net Income to Common | -46.13 | -42.21 | -58.51 | -63.66 | -49.85 | -46.97 | |
| Shares Outstanding (Basic) | 55 | 48 | 34 | 28 | 23 | 21 | |
| Shares Outstanding (Diluted) | 55 | 48 | 34 | 28 | 23 | 21 | |
| Shares Change (YoY) | 23.82% | 41.56% | 21.35% | 20.29% | 12.06% | 21.48% | |
| EPS (Basic) | -0.83 | -0.88 | -1.72 | -2.28 | -2.14 | -2.26 | |
| EPS (Diluted) | -0.83 | -0.88 | -1.72 | -2.28 | -2.14 | -2.26 | |
| Free Cash Flow | -34.1 | -33.16 | -47.41 | -54.53 | -35.81 | -34.79 | |
| Free Cash Flow Per Share | -0.61 | -0.69 | -1.40 | -1.95 | -1.54 | -1.68 | |
| Gross Margin | - | - | - | -38.79% | - | - | |
| Operating Margin | - | - | -8293.86% | -4443.86% | - | - | |
| Profit Margin | - | - | -8357.86% | -4489.42% | - | - | |
| Free Cash Flow Margin | - | - | -6773.43% | -3845.84% | - | - | |
| EBITDA | -47.33 | -42.37 | -56.7 | -61.87 | -48.87 | -46.79 | |
| D&A For EBITDA | 1.2 | 1.21 | 1.36 | 1.15 | 1.1 | 1.16 | |
| EBIT | -48.53 | -43.57 | -58.06 | -63.01 | -49.97 | -47.95 | |
| Revenue as Reported | - | - | 0.7 | 1.42 | - | - | |
Source: S&P Capital IQ. Standard template.
Financial Sources.